Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Last: | $4.06 |
---|---|
Change Percent: | -0.72% |
Open: | $4.17 |
Close: | $4.06 |
High: | $4.225 |
Low: | $4.03 |
Volume: | 3,047,134 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
2024-05-22 16:11:06 ET Summary Anavex Life Sciences is a clinical-stage biopharmaceutical company developing innovative treatments for neurodegenerative diseases. Its leading drug candidate, Anavex 2-73 (Blarcamesine), targets the Sigma-1 and muscarinic receptors in the brain to e...
2024-05-22 11:15:20 ET More on Anavex Life Sciences Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Anavex Life Sciences Historical earnings data for Anavex Life Sciences Financial information for Anav...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Subject | By | Source | When |
---|---|---|---|
Excellent all around. Glad Xena posted the amounts | k9uwa | investorshub | 06/02/2024 2:07:29 AM |
Thanks Xena. | k9uwa | investorshub | 06/02/2024 2:00:45 AM |
Simple answer: contractual obligation. | XenaLives | investorshub | 06/02/2024 1:10:19 AM |
sarcasm noted | XenaLives | investorshub | 06/02/2024 12:59:23 AM |
Xena, Thank you very much!!! | georgejjl | investorshub | 06/02/2024 12:36:53 AM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceuti...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...